The potential
for iron overload (liver haemosiderosis) and cardiac arrhythmias are also a concern. This guideline has been rewritten to address both this clinical effect and to provide a practical guide to iron usage by physicians, nephrologists and renal nursing teams. Overall the recent Cochrane review[6] has both confirmed that IV iron is appropriate and useful in achieving Hb and iron targets and significantly better than oral iron with minimal clinical toxicity. The monitoring of iron and mode of delivery is still based on small cohort studies of the apparent effective targets Afatinib whether in dialysis or just CKD alone and in patients with or without the use of an ESA. Both the resistance to iron and the use of adjuncts
like Vitamin C or different iron compounds is not at this stage with sufficient clinical evidence to recommend them in standard care in the long term. *Explanation of grades The evidence and recommendations in this KHA-CARI guideline have been evaluated and graded selleck screening library following the approach detailed by the GRADE working group (http://www.gradeworkinggroup.org). A description of the grades and levels assigned to recommendations is provided in Tables 1 and 2. **Access to the full text version For a full text version of the guideline, readers need to go to the KHA-CARI website (http://www.cari.org.au). “
“Mark A Brown and Susan M Crail Nephrologists seek to provide dialysis to those
who will benefit most while being honest and direct with those who are unlikely to benefit or even be harmed by dialysis; these can be difficult decisions. A ‘conservative’ or ‘not for dialysis’ pathway is an important option for the management of end-stage Cyclooxygenase (COX) kidney disease (ESKD) patients who are elderly, have significant comorbidity, poor functional status, malnutrition or who reside in a nursing home. Such a pathway is best underpinned by a specific renal supportive care programme in each unit. Nephrologists need to lead realistic discussions about likely survival with patients and their families before dialysis is instituted. Key ethics principles are a good aid in this decision-making process A ‘non-dialysis’ renal supportive care programme is a very positive way of offering holistic care for patients and their families; many of these patients live much longer without dialysis than might have been expected. Perhaps the most difficult decision facing nephrologists today is that of ‘selecting’ which patients will benefit from dialysis in an overall person-centred sense, not just in terms of days survived or achievement of target haemoglobin, Phosphate, Kt/V or other outcomes. The overall aim is to help and direct patients and their families so as to encourage those who will benefit most from dialysis to have this while being honest and direct with those who are unlikely to benefit or even be harmed by dialysis.